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Background: Mortality rate, the possible factors affecting mortality and intubation
in patients with acute exacerbation of chronic obstructive pulmonary diseases
(COPD) and hypercapnic respiratory failure (RF) are yet unclear.
Objective: To identify the possible factors affecting mortality and intubation in
COPD patients.
Design: A prospective study using data obtained over the first 24 h of respiratory
intensive care unit (RICU) admission. Consecutive admissions of 656 patients were
monitored and 151 of them who had acute exacerbation of COPD and hypercapnic RF
were enrolled.
Setting: University hospital, Department of Chest Diseases, RICU.
Results: Mean age was 65.1 years. The mean APACHE II score was 23.7. Eighty-seven
patients (57.6%) received mechanical ventilation (MV) via an endotracheal tube for
more than 24 h. Twenty-two patients received non-invasive ventilation (NIV). Fifty
patients died (33.1%) in hospital during the study period. The mortality rate was
52.9% in patients in need of MV. In the multivariate analysis, the need for intubation,
inadequate metabolic compensation for respiratory acidosis, and low ( ¼ bad)
Glasgow Coma Score (GCS) were determined as independent factors associated with
mortality. The low GCS (OR: 0.61; CI: 0.48–0.78) and high APACHE II score (OR: 1.24;
CI: 1.11–1.38) were determined as factors associated with intubation.
Conclusion: The most important predictors related to hospital mortality were the
need for invasive ventilation and complications to MV. Adequate metabolic
compensation for respiratory acidosis at admittance is associated with betterElsevier Ltd. All rights reserved.
in the Annual Congress of European Respiratory Society, Berlin, Germany, 2001.
2392979x3050; fax: +90 222 2394714.
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Outcome in patients with COPD and hypercapnia 67survival. A high APACHE II score and loss of consciousness (low GCS) were
independent predictors of a need to intubate patients.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Exacerbation of chronic obstructive pulmonary
disease (COPD) is the fourth leading cause of
death.1 Patients with COPD requiring admission to
an intensive care unit (ICU) for acute hypercapnic
respiratory failure (RF) usually have a poor out-
come and consume a large amount of resources, in
the case of a need for intubation, in particular.
These patients have high mortality rates, with
reported rates varying between 6% and 24%
depending on the type of unit, co-existing diseases
and characteristics of the patients involved, as well
as the severity of their illnesses.2–14 These rates
increase to 14–57% as ventilatory support becomes
inevitable.7,9,10,12,15–18 Determining the factors
predicting mortality and intubation are of interest
to intensivists, because early identification of
patients at high risk is essential, as well as tailoring
monitoring, therapy and counseling families.
Many factors have been identified as predictors
of ICU mortality9–13,16–19 in patients with COPD.
They are as follows; RF requiring mechanical
ventilation (MV), severity of underlying disease,
renal failure, sepsis, presence of malignancy, age,
some biochemical and physiologic parameters,
cardiac failure—arrhythmia, body mass index, and
APACHE II scores. Hypercapnic RF has a significant
effect on prognosis in patients with COPD.20–22
Besides, there are some contradictory results upon
the effects of MV, which suggest that MV does not
have an independent effect on mortality.9–11,15
This study aims to determine the hospital
mortality rate and the factors affecting mortality
and intubation for patients admitted for acute
exacerbation of COPD and hypercapnic RF to the
respiratory ICU (RICU).Materials and methods
Patients
This study was carried out in the RICU at Osmangazi
University, Medical Faculty, Department of Chest
Diseases, between January 1999 and February
2004. We analyzed prospectively the data collected
from patients admitted for acute exacerbation of
COPD and hypercapnic RF to the RICU. Consecutive
admissions of 656 patients to the RICU weremonitored. The patients with the following condi-
tions were all excluded from the study; acute
respiratory distress syndrome, massive pulmonary
embolism, malignancy, RF due to reasons other
than COPD, and COPD without hypercapnia. Those
who died within the first 24 h following admission to
the RICU were also excluded. The remaining 151
patients with COPD and hypercapnic RF were all
enrolled in the study. This study gained approval of
the Ethical Practices Committee of Osmangazi
University.
The university medical center is an 800-bed
hospital. It has a six-bed RICU staffed by a full-
time chest physician. The ratio of nurses to patients
was 1:3 per shift during the conduction of the
study.Descriptions and follow-up
COPD has been defined as the presence of airway
obstruction attributable to chronic bronchitis or
emphysema. Additional chart review also con-
firmed that these patients fulfilled American
Thoracic Society guidelines for the diagnosis of
COPD.23 The presence of acute exacerbation or
‘flares’ was determined if at least two of the
following symptoms increased: dyspnea, sputum
production, and/or sputum purulence. Acute hy-
percapnic RF was defined by arterial blood gas
criteria [partial pressure of carbon dioxide: Pa-
CO2445mmHg (6 kPa), and pHo7.35].24
Patients’ characteristics were all duly recorded.
These included age, gender, Acute Physiology and
Chronic Health Evaluation II Score (APACHE II),
primary diagnosis, co-morbid diseases, source of
admission referral, length of hospital and RICU stay,
prior antibiotic use, smoking and alcohol habits,
physical examination findings. All the necessary
laboratory data for the first 24 h of RICU admission
(complete blood count, biochemical analysis, elec-
trocardiogram, chest X-ray, and arterial blood
gases), a need for MV, non-invasive ventilation
(NIV), complications during the MV and outcome of
the patients were the other characteristics. Since
the patients with COPD and hypercapnic RF were
sustaining severe bronchial obstruction, and their
general status did not give permission, physiologic
assessment with pulmonary function tests could not
be performed in all patients.
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unfavorable values available during the first 24 h in
the RICU as described in the literature.4 The
Glasgow Coma Score (GCS)25 was used to estimate
the level of consciousness, and it was considered
that a high value is good (such as 15 points) and
that a low value is bad. Ventricular arrhythmias
(ventricular tachycardia and fibrillation), atrial
tachyarrhythmias (atrial fibrillation and flutter)
and bradyarrhythmia were recorded. The duration
of stay in the RICU was defined according to the
number of the days between RICU admission and
discharge. As for the duration of the hospital stay,
it was defined according to the number of the days
between hospital admission and discharge, with a
minimum stay of 1 day. The primary outcome
studied was in-hospital mortality. Data were then
entered into a computer database and checked by
another researcher for errors. Survival status was
recorded upon hospital discharge.
Patients received controlled oxygen therapy via
nasal canula in order to achieve a level of arterial
oxygen saturation of 90%, and also subcutaneous
low-molecular-weight heparin, antibiotic agents,
histamine-2 receptor blocker and bronchodilators
(nebulized b-2 agonists, anticholinergic therapy,
and intravenous aminophylline) and/or steroid
treatment were administered.Mechanical ventilation
Whether invasive or non-invasive ventilation should
be used was determined by the physician under-
taking the study in RICU. We used the criteria for
indications for intubation in acute RF.26 These
criteria were: (1) apnea or respiratory pauses with
loss of consciousness or gasping for air or imminent
respiratory arrest, (2) acute exacerbation of COPD
with hypercapnic RF, tachypnea or severe dyspnea
plus at least one of the following (a) altered mental
status of persistent uncooperativeness; (b) acute
cardiovascular instability; (c) inability to protect
the lower airway or copious secretions; (d) patients
who could not tolerate NIV or progressive respira-
tory acidosis despite intensive initial therapy.
Patients in need of endotracheal intubation were
mechanically ventilated with Amadeus (Hamilton,
Via Nova, Switzerland) and Esprit (Respironics, PA,
USA) ventilators in the assist—control or synchro-
nized intermittent mandatory ventilation (SIMV)
mode. BIPAP Vision machine (Respironics, PA, USA)
were used for NIV. Weaning from the MV began as
soon as the patient was capable of initiating a
spontaneous breath and then weaned by progres-sive reduction in pressure support ventilation as far
as he/she could tolerate.Statistical analysis
At the first stage of the analysis, we used
descriptive statistics to characterize the patient
sample, using means with standard deviations (SD),
and with medians, used in the eligible data. Thirty-
two variables were assessed for each patient using
the w2-test for categorical variables and an un-
paired student’s t-test or Mann–Whitney U-test for
continuous variables.
We created three types of multiple logistic
regression models. The first aimed to determine
the factors associated with mortality in all COPD
patients. The second aimed to determine the
factors associated with mortality of the patients
who were mechanically ventilated. The last one
aimed to uncover the factors influencing the
decision of intubation. Multiple logistic regression
analysis, along with backward stepwise analysis,
was performed to examine the correlation between
patient characteristics and outcome. All compar-
isons of clinical variables with a P value of lower
than 0.05 by univariate analysis were entered into
the model.
A receiver operating characteristic (ROC) curve
for the assessment of the predictive value of RICU
mortality using the APACHE II score was constructed
by plotting the sensitivities for all individual cut-off
values vs. the corresponding (1-specificity).27 In
order to achieve a global measure of the criteria’s
discrimination, the area under the ROC curve was
calculated. Data were processed using SPSS for
Windows 12.0 (SPSS, Chicago, IL). A P value o0.05
was considered to be of statistical significance.Results
The mean age was 65.1710.9 years (range 41–97
year), 115 of patients (74.4%) were males, and 36
were females. Thirty-two (21.2%) patients were
receiving long-term oxygen therapy in their houses
and three of them were using NIV via a nasal mask.
Fifty-eight percent of them were housebound. Most
of the patients (86.8%) were referrals from the
emergency department. Acute RF resulting in RICU
admission was most often associated with an
exacerbation of COPD with normal chest X-ray
(49.7%, 75 patients). On admission to hospital,
29.1% of the patients had an acute exacerbation of
COPD with pneumonia.
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ity. The mean APACHE II score was 23.774.9.
Thirty-eight patients died (25.2%) in a RICU and 50
patients died (33.1%) in the hospital during the
study period. The mean lengths of RICU and
hospital stays were 6.9 and 10.4 days, respectively.
General characteristics, the causes of an acuteTable 1 Differences in baseline characteristics and la
(univariate analysis).
Parameters All patients (n ¼ 151)
Survivors
(n ¼ 101)
Non-survivo
(n ¼ 50)
Age (year) (mean7SD) 64.079.8 67.4712.8
Gender (M/F) 75/26 40/10
Cause of acute attack
COPD exacerbation, no. (%) 60 (59.4%) 15 (30%)
Pneumonia or Sepsis, no. (%) 25 (24.8%) 19 (38%)
Cardiac failure, no. (%) 10 (9.9%) 14 (28%)
Other, no. (%) 6 (5.9%) 2 (4%)
Respiratory rate 28.376.2 30.278.0
Presence of co-morbidity, no. (%) 32 (31.7%) 26 (52%)
Sepsis 43 (42.6%) 38 (76%)
SBP (mmHg) 126724 116730
DBP (mmHg) 73714 65718
Cardiac arrhythmias, no. (%) 14 (13.9%) 16 (32%)
GCS (mean7SD) 13.272.7 10.373.1
APACHE II score (mean7SD) 22.474.7 26.374.2
Length of RICU stay (days) 7.175.5 6.375.1
Length of hospital stay (days), 11.978.2 7.375.7
Mechanical ventilation, no. (%) 41 (41%) 46 (92%)
Complication of MV, no. (%) 2 (2%) 12 (24%)
Laboratory variables
Hemoglobin (g/dl) 14.772.2 13.372.1
WBC (106/ml) 14.777.7 15.878.0
Glucose (mg/dl) 173795 151798
K (mEq/l) 4.771.1 4.670.8
Creatinine, mg/dl 1.370.6 1.771.2
LDH (IU) 8847901 10237882
Total protein (g/dl) 6.470.8 6.071.0
CRP (mg/dl) 6.978.3 14.1711.6
Sedimentation rate (mm/h) 21.6730.5 21.3732.2
Arterial blood gases
PaO2mmHg (kPa) 52.9 (7.0) 52.5 (7.0)
PaO2/FiO2 mmHg (kPa) 183 (24.3) 169 (22.5)
PaCO2mmHg (kPa) 69.4 (9.2) 63.9 (8.5)
pH 7.2570.10 7.2170.10
HCO3 (mmol/l) 28.676.8 24.276.3
Data are presented as mean7SD unless otherwise indicated. SBP,
Glasgow Coma Score; APACHE, acute physiology and chronic heal
cells; K, potassium; LDH, lactic dehydrogenase; CRP, C reactive p
arterial carbon dioxide pressure; pH, arterial blood pH.
*Statistically significant.
Between acute exacerbation of COPD and cardiac failure.exacerbation of COPD and some of the laboratory
results are presented in Table 1.
There was a significant difference between
survivors and non-survivors regarding the causes
of acute hypercapnic RF. The mortality rate was
20% of patients with acute exacerbation of COPD,
while it was 58% for patients with congestive heartboratory data between survivors and non-survivors
Invasively ventilated patients (n ¼ 87)
rs P Survivors
(n ¼ 41)
Non-survivors
(n ¼ 46)
P
0.10 66.2077.5 67.7713.2 0.51
0.54 29/12 38/8 0.21
0.002 28 (68.3%) 15 (32.6%) 0.003
9 (21.9%) 17 (37%)
2 (4.9%) 12 (26.1%)
2 (4.9%) 2 (4.3%)
0.32 27.276.8 28.676.9 0.54
0.02* 8 (19.5%) 24 (52.2%) 0.002*
0.001* 9 (22.0%) 21 (45.7%) 0.025*
0.04* 124720 118731 0.27
0.002* 74714 66717 0.018*
0.016* 8 (19.5%) 14 (30.4%) 0.32
o0.001* 11.673.5 10.173.2 0.053
o0.001* 24.374.0 26.774.1 0.007*
0.41 10.176.6 6.775.1 0.01*
0.001* 15.078.7 7.675.9 o0.001*
o0.001* – –
0.001* 2 (4.9%) 12 (26.1%) 0.002*
0.001* 14.572.1 13.472.2 0.023*
0.39 13.976.7 16.078.3 0.19
0.18 164755 1547102 0.59
0.32 5.071.3 4.670.8 0.16
0.03* 1.570.7 1.771.2 0.27
0.38 125671248 10597913 0.41
0.02* 6.370.8 6.071.0 0.12
0.001* 8.8 710.1 14.0711.9 0.04*
0.11 16.5728.9 25.1733.6 0.20
0.93 56.7 (7.5) 52.8 (7.0) 0.47
0.30 200 (26.6) 169 (22.5) 0.06
0.012* 75.8 (10.1) 64.5 (8.6) 0.001*
0.045* 7.2170.11 7.2070.97 0.75
0.001* 28.476.9 24.076.5 0.003*
systolic blood pressure; DBP, diastolic blood pressure; GCS,
th evaluation; MV: mechanical ventilation, WBC, white blood
rotein; PaO2, partial arterial oxygen pressure; PaCO2, partial
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sion was strongly correlated with mortality
(Po0:001).
Univariate analysis determined that 18 para-
meters were found to show a statistically signifi-
cant difference between survivors and non-
survivors (Table 1). In intubated patients both the
cause of the acute attack of COPD, presence of co-
morbidity, sepsis, diastolic blood pressure (DBP),
length of hospital stay and RICU stay, APACHE II
score on admission, complications of MV, serum
hemoglobin, C-reactive protein (CRP) levels, arter-
ial blood PaCO2, HCO3 levels, and inadequate
metabolic compensation for respiratory acidosis
were found to show a statistically significant
difference between survivors and non-survivors
(Table 1).
The indications of intubation were apnea or
respiratory pauses (37 patients), acute exacerba-
tion of COPD with hypercapnic RF, and altered
mental status of persistent uncooperativeness (26
patients), and acute cardiovascular instability (10
patients), inability to clear secretion—a need for
airway protection (six patients), and patients who
could not tolerate NIV or progressive respiratory
acidosis despite intensive initial therapy (eight
patients). The average duration of MV was
5.474.2 days (range 1–24). Twenty-two patients
received NIV (14.6%). Eight of them were intubated
due to the failure of NIV (36.4%). The mortality rate
of the patients who failed to respond to NIV was
75%. Eighty-seven patients received MV via an
endotracheal tube (57.6%) for more than 24 h.
Mortality rate was 52.9% in patients in need of
invasive MV. Tracheotomy was performed in three
patients. Fourteen (16.1%) of the mechanically
ventilated patients had some complications (eleven
of them had ventilator-associated pneumonia, and
three of them had pneumothorax). These patients
with complications had a much worse outcome than
those without complications (P ¼ 0:001).
A comparison was also made between intubated
and not-intubated patients in Table 2. Univariate
analysis determined that 10 factors were signifi-
cantly different between intubated and non-intu-
bated patients. These parameters were age, GCS,
length of RICU stay, APACHE II score, serum
creatinine, lactic dehydrogenase, CRP levels, ar-
terial blood pH, PaCO2, and HCO3 levels.
Based on the univariate analysis, 18 variables
were determined to be significantly different
between survivors and non-survivors. These vari-
ables were entered into a multiple logistic regres-
sion model to evaluate their independent
prognostic roles (except for ‘length of hospital
stay’). As shown in Table 3, the need for invasiveventilation, complications of MV, inadequate meta-
bolic compensation for respiratory acidosis, DBP,
serum hemoglobin count, and GCS were all deter-
mined as factors associated with hospital mortality
of patients with COPD treated in the RICU. The
effects of low DBP, low GCS, and inadequate
metabolic compensation were positively correlated
to mortality.
In the second model, 12 variables (except for
‘length of hospital and RICU stay’) that were
determined in the univariate analysis between
survivors and non-survivors in the intubated pa-
tients were entered into a multiple logistic regres-
sion model. As shown in Table 3, the presence of co-
morbid diseases and inadequate metabolic com-
pensation for respiratory acidosis were determined
as factors associated with hospital mortality in
invasively ventilated COPD patients with hypercap-
nic RF.
In the third model, 10 variables that were
determined to be significantly different between
intubated and non-intubated patients were entered
into a multiple logistic regression model (except for
‘length of RICU stay’). As shown in Table 3, in the
multivariate analysis, the GCS (odds ratio (OR):
0.61; confidence intervals (CI): 0.48–0.77)) and
APACHE II score (OR: 1.24; CI: 1.11–1.38) were
determined as independent factors associated with
intubation (Table 3).
The sensitivity and specificity of the presence of
one or two independent factors associated with
intubation (APACHE II score423, and GCSo9) were
found to be 81.6% and 68.7%, respectively. The area
under the ROC curve was 0.81 for these criteria
(Fig. 1).Discussion
The RICU mortality of COPD patients with hyper-
capnic RF was 25.2%, and in-hospital mortality was
33.1% in our study. These rates were found as 8% in
patients not requiring MV and as 52.9% in patients
requiring MV. Our study included all acute exacer-
bation of COPD patients with hypercapnic RF. The
reported mortality rate of patients with COPD and
acute RF was 26% before 1975, compared to 10%
after 1975.18 The average mortality rate of patients
with COPD not requiring RICU was 2.5–14.4%,1,7,13
it ranged between 6% and 24% for those requiring
RICU,2–14 and it was 14–57% in patients requiring
MV.7,9,10,12–18,21 Some studies excluded patients
with COPD whose RF was due to such precipitating
factors as pulmonary embolism, heart failure,
pneumonia and pneumothorax and who need MV.
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Table 2 Differences between intubated and non-intubated patients (univariate analysis).
Non-intubated (n ¼ 64) Intubated patients (n ¼ 87) P value
Age (year) (mean7SD 62.5710.6 67.0710.8 0.01*
Gender (M/F) 48/16 67/20 0.85
Cause of acute attack
COPD exacerbation, no. (%) 32 (50.0%) 43 (49.4%) 0.89
Pneumonia or sepsis, no. (%) 18 (28.1%) 26 (29.9%)
Cardiac failure, no. (%) 10 (15.6%) 14 (16.1%)
Other, no. (%) 4 (6.3%) 4 (4.6%)
Presence of comorbidity, no. (%) 26 (40.6%) 32 (36.8%) 0.74
Sepsis 34 (53.1%) 47 (54.0%) 40.99
SBP (mmHg) 125727 121726 0.33
DBP (mmHg) 71716 70716 0.60
Cardiac arrhythmias, no. (%) 8 (12.5%) 22 (25.3%) 0.06
GCS (mean7SD) 14.171.4 10.873.4 0.001*
APACHE II score (mean7SD) 21.274.7 26.574.2 o0.001*
Length of RICU stay (days) 4.873.2 8.376.1 0.001*
Length of hospital stay (days), 9.477.1 11.178.2 0.17
Laboratory variables
Hemoglobin (g/dl) 14.672.1 13.972.2 0.06
WBC (103/ml) 1508478171 1503877603 0.97
Glucose (mg/dl) 1767113 158783 0.29
K (mEq/l) 4.670.9 4.871.1 0.31
Creatinine (mg/dl) 1.2470.77 1.5870.99 0.02*
LDH (IU) 6317384 115471085 0.001*
Total protein (g/dl) 6.470.8 6.270.9 0.11
CRP (mg/dl) 5.876.5 11.3711.2 0.001*
Sedimentation rate (mm/h) 23.2731.2 25.8731.5 0.67
Arterial blood gases
PaO2mmHg (kPa) 50.2 (6.7) 54.6 (7.3) 0.30
PaO2/FiO2mmHg (kPa) 171 (22.7) 184 (24.5) 0.34
PaCO2mmHg (kPa) 64.6 (8.6) 69.8 (9.3) 0.016*
pH 7.2770.09 7.2170.10 0.001*
HCO3 (mmol/l) 28.576.5 26.177.0 0.03*
Data are presented as mean7SD unless otherwise indicated. SBP, systolic blood pressure; DBP, diastolic blood pressure; GCS,
Glasgow coma score; APACHE, acute physiology and chronic health evaluation. WBC, white blood cells; K, potassium; LDH, lactic
dehydrogenase; CRP, C reactive protein; PaO2, partial arterial oxygen pressure, PaCO2, partial arterial carbon dioxide pressure;
pH, arterial blood pH.
*Statistically significant.
Outcome in patients with COPD and hypercapnia 71Differences in disease severity and diversity of the
patients may partly explain the variations in
hospital outcome. The median APACHE II score
was 24 in our study.4 In the other series, the
APACHE II scores were reported to change between
11 and 22.9,11,12,15,16,18,26 We attributed the higher
mortality rate in our study to the greater severity
of the illness, higher APACHE II point and high
intubation rate.
Our study identified several independent risk
factors for in-hospital mortality using information
obtainable from administrative databases in the
multivariate analysis. A need for invasive ventila-
tion, and presence of complication of MV wereassociated with an increased risk of in-hospital
mortality for COPD patients with acute hypercapnic
RF being treated in the RICU. Similarly, inadequate
metabolic compensation for respiratory acidosis,
low blood hemoglobin level, low GCS and low DBP
were identified as independent risk factors for
mortality, too. In other studies, the need for MV for
3 days or longer,18 high APACHE II
score,9,11,12,18,19,28 presence of cardiac arrhyth-
mia,7,29–31 coma,17 low hemoglobin level,32 sepsis,
iatrogenic complication, renal failure,33 advanced
age, low GCS (GCSo8),34 and pulmonary infiltra-
tion in the chest X-ray21 have previously been
reported as significant predictors of in-hospital
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Table 3 Multiple logistic regression analysis of the association of hospital mortality and intubation with
potential prognostic factors.
Parameters P value Odds ratio 95% CI
Factors effecting mortality
All COPD patients
Need for invasive ventilation 0.008 17.09 2.09–139.77
Complications of invasive ventilation 0.010 10.49 1.76–62.41
Adequate metabolic compensation 0.007 0.14 0.04–0.58
Serum hemoglobin 0.006 0.63 0.45–0.88
GCS 0.003 0.74 0.61–0.90
DBP 0.010 0.95 0.91–0.99
Mechanically ventilated patients
Presence of co-morbidityy o0.001 16.32 3.22–82.63
Adequate metabolic compensation 0.003 0.07 0.01–0.41
Factors effecting intubation and MV
High APACHE II score o0.001 1.24 1.11–1.38
Low GCS o0.001 0.61 0.48–0.77
CI, confidence intervals; COPD, chronic obstructive pulmonary diseases; GCS, Glasgow Coma Score; DBP, diastolic blood
pressure. APACHE II, Acute Physiology and Chronic Health Evaluation Score II.
Adequate metabolic compensation for respiratory acidosis.
yEspecially congestive heart failure.
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Figure 1 ROC analysis curve for the determination of
intubation for patients with COPD and hypercapnic
respiratory failure (at least one of the following: APACHE
II score 423, and/or GCSo9). The area under the ROC
curve was 0.81.
I. Ucgun et al.72mortality among patients with COPD and acute RF.
On the other hand, some authors reported that the
need for intubation was not a significant predictor
of in-hospital mortality among patients with COPD
and acute RF.9–11,15Differences in age, gender, cause of acute attack
of COPD, presence of co-morbidity, sepsis, systolic
blood pressure (SBP), APACHE II score, failure of
NIV, serum creatinine, total protein, CRP levels,
arterial blood gas pH, PaCO2, HCO3 between
survivors and non-survivors were insignificant in
the multivariate analysis. Previous studies have
identified some physiological factors such as FEV1
and arterial blood gas abnormalities as important
predictors of mortality.7,11,17,19 While the meta-
bolic alkalosis was reported to show various
affects, inclusive of the central nervous system,
myocardium, skeletal muscle, liver and ventilation,
we demonstrated in our study, that adequate
compensatory metabolic alkalosis for respiratory
acidosis independently decreased mortality in
patients with COPD and hypercapnic RF.
MV is undoubtedly a lifesaving procedure for
patients with acute RF. In our study, 57.6% of the
patients underwent invasive MV (87 patients) for a
median of 5 days (ranging between 1 and 22 days).
Patients requiring intubation and MV had 52.9%
mortality (46 patients). In other studies, 22–85%
patients with acute exacerbation of COPD needed
invasive MV for a median of 2–36
days.7,9–11,15,16,21,24 Upon a multivariate analysis
of the mechanically ventilated patients, we de-
monstrated that the patients having co-morbidity
(especially congestive heart failure) showed even
worse outcomes, while the patients with adequate
metabolic compensation showed better ones.
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APACHE II score were found to affect the likelihood
of intubation independently upon the multivariate
logistic regression analysis. In the previous studies,
higher APACHE II score and acidosis were reported
to be an independent risk factor for intubation,
too.35,36 Patients having an impairment of mental
status (GCSo9) and higher APACHE II scores (423
points) are at high risk for intubation. Likewise, our
study disclosed that the sensitivity and specificity
of the presence of at least one of these factors
related to intubation were found to be 81.6% and
68.7%, respectively.
The following are the limitations of our study: a
relatively low number of patients, a relatively low
rate of NIV applications, inclusion of not only
patients with uncomplicated acute exacerbation
of COPD but also those with pneumonia and heart
failure leading to acute exacerbation of COPD.
We concluded that patients admitted to a
respiratory ICU for acute hypercapnic RF due to
COPD are at substantial risk for hospital death. The
most important predictors related to hospital
mortality are the need for invasive ventilation
and complications to MV. Adequate metabolic
compensation for respiratory acidosis at admit-
tance is associated with better survival. A high
APACHE II score and loss of consciousness (low GCS)
are independent predictors of a need to intubate
patients with COPD and hypercapnic RF.Acknowledgements
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